Table 3.
Rotation Score and Other Measures of Insulin Injection Rotation (Secondary Endpoints) in 31 Participants with Type 1 Diabetes.
| Metric | Baseline |
Intervention week 1 |
Intervention week 12 |
|||||
|---|---|---|---|---|---|---|---|---|
| n | Mean (±SD) | Mean (±SD) | Mean change [CI]a | P-valueb | Mean (± SD) | Mean change [CI]a | P-valueb | |
| Rotation score (%) | 31 | 39.6% (±16.4) | 49.2% (±20.2) | 9.6% [1.2%; 18.0%] | .025 | 52.2% (±13.0) | 12.6% [5.2%; 19.9%] | <.001 |
| Percentage of fields used | 31 | 58.7% (±15.7) | 66.7% (±22.4) | 8.0% [0.3%; 15.8%] | .042 | 69.9% (±21.4) | 11.3% [4.0%; 18.6%] | .002 |
| Field reuse count (fields) | 30 | 2.7 (±1.6) | 3.7 (±1.9) | 1.0 [0.1; 1.9] | .034 | 6.9 (±2.1) | 4.2 [3.3; 5.1] | <.001 |
CI, confidence interval; SD, standard deviation.
Baseline, 1-week, and 12-week results are reported.
a
95% confidence interval on change from baseline.
b
Paired z test, compared with baseline.